News | Coronavirus (COVID-19) | December 23, 2021

Interdisciplinary research team from Göttingen University and Hannover Medical School are first to prove this directly

Vascular network (red) in healthy heart tissue (left) and in severe Covid-19 (right). Due to faulty reforming of the network as a result of Covid-19, numerous branches, splits and even loops develop in the capillaries, which can be analysed mathematically. Image courtesy of M. Reichardt, P. Møller Jensen, T. Salditt

Vascular network (red) in healthy heart tissue (left) and in severe Covid-19 (right). Due to faulty reforming of the network as a result of Covid-19, numerous branches, splits and even loops develop in the capillaries, which can be analyzed mathematically. Image courtesy of M. Reichardt, P. Møller Jensen, T. Salditt


December 23, 2021 — An interdisciplinary research team from the University of Göttingen and Hannover Medical School (MHH) has detected significant changes in the heart muscle tissue of people who died from Covid-19. Damage to lung tissue has been the research focus in this area for some time and has now been thoroughly investigated. The current study underpins the involvement of the heart in Covid-19 at the microscopic level for the first time by imaging and analyzing the affected tissue in the three dimensions. The results were published in the journal eLife.

The scientists imaged the tissue architecture to a high resolution using synchrotron radiation – a particularly bright X-ray radiation – and displayed it three-dimensionally. To do this, they used a special X-ray microscope that the University of Göttingen set up and operates at the German Electron Synchrotron DESY in Hamburg. They observed clear changes at the level of the capillaries (the tiny blood vessels) in the heart muscle tissue when they examined the effects there of the severe form of Covid-19 disease.

In comparison with a healthy heart, X-ray imaging of tissues affected by severe disease, revealed a network full of splits, branches and loops which had been chaotically remodelled by the formation and splitting of new vessels. These changes are the first direct visual evidence of one of the main drivers of lung damage in Covid-19: a special kind of “intussusceptive angiogenes” (meaning new vessel formation) in the tissue.

In order to visualise the capillary network, the vessels in the three-dimensional volume first had to be identified using machine learning methods. This initially required researchers to painstakingly, manually label the image data.  "To speed up image processing, we therefore also automatically broke the tissue architecture down into its local symmetrical features and then compared them," explains Marius Reichardt, at the University of Göttingen and first author of the paper. "The parameters obtained from this then showed a completely different quality compared to healthy tissue, or even to diseases such as severe influenza or common myocarditis," explain the leaders of the study, Professor Tim Salditt from the University of Göttingen and Professor Danny Jonigk from the MHH.

There is a very special feature of this study: in contrast to the vascular architecture, the required data quality could be achieved using a small X-ray source in the laboratory of the University of Göttingen. In principle, this means it could also be done in any clinic to support pathologists with routine diagnostics. In the future, the researchers want to further expand the approach of converting the characteristic tissue patterns into abstract mathematical values in order to develop automated tools for diagnostics, again by further developing laboratory X-ray imaging and validating it with data from synchrotron radiation. The collaboration with DESY will be further expanded in the coming years.

For more information: www.roentgen.physik.uni-goettingen.de

Related COVID-19 Imaging and Myocarditis Content:

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

COVID-19 Linked to Heart Inflammation in College Athletes — RSNA 2021 late-breaker

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Large International Study Reveals Spectrum of COVID-19 Brain Complications - RSNA 2021 late-breaker

COVID-19 During Pregnancy Doesn’t Harm Baby’s Brain

VIDEO: Large Radiology Study Reveals Spectrum of COVID-19 Brain Complications — Interview with Scott Faro, M.D.

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination

 


Related Content

News | Cardiac Imaging

May 20, 2025 — Royal Philips has launched the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter ...

Time May 27, 2025
arrow
News | Pediatric Imaging

May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric ...

Time May 20, 2025
arrow
News | X-Ray

May 01, 2025 — Researchers from the Rajpurkar Lab in the Department of Biomedical Informatics at Harvard Medical School ...

Time May 01, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Radiology Imaging

Dec. 4, 2024 – Konica Minolta Healthcare Americas and Gleamer have announced a strategic partnership to help ...

Time December 06, 2024
arrow
News | Radiology Imaging

Nov. 13, 2024 — Agfa Radiology Solutions will feature live demonstrations of state-of-the-art digital X-ray rooms ...

Time November 14, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Radiology Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Time July 23, 2024
arrow
Subscribe Now